Ethopabate BP
BP-grade Ethopabate antiprotozoal compound for veterinary pharmaceutical manufacturers requiring regulatory-compliant coccidiostat ingredients.
Commercial quotation provided within 48 hours.
About Ethopabate BP
Ethopabate BP is a pharmaceutical-grade antiprotozoal compound manufactured to British Pharmacopoeia standards. This synthetic coccidiostat belongs to the quinazolinone class and demonstrates efficacy against Eimeria species in poultry applications. The compound exhibits excellent stability and bioavailability characteristics essential for veterinary pharmaceutical formulations. Our BP-grade material meets stringent purity requirements exceeding 99% active ingredient content with comprehensive certificate of analysis documentation. Suitable for manufacturers developing veterinary medicines and feed additives requiring regulatory compliance. The crystalline powder form enables easy integration into premixes and medicated feeds. Quality assurance includes heavy metals testing, residual solvents analysis, and microbiological screening to ensure pharmaceutical manufacturing standards.